Quantitative SUMO proteomics reveals the modulation of several PML nuclear body associated proteins and an anti-senescence function of UBC9

Sci Rep. 2018 May 17;8(1):7754. doi: 10.1038/s41598-018-25150-z.

Abstract

Several regulators of SUMOylation have been previously linked to senescence but most targets of this modification in senescent cells remain unidentified. Using a two-step purification of a modified SUMO3, we profiled the SUMO proteome of senescent cells in a site-specific manner. We identified 25 SUMO sites on 23 proteins that were significantly regulated during senescence. Of note, most of these proteins were PML nuclear body (PML-NB) associated, which correlates with the increased number and size of PML-NBs observed in senescent cells. Interestingly, the sole SUMO E2 enzyme, UBC9, was more SUMOylated during senescence on its Lys-49. Functional studies of a UBC9 mutant at Lys-49 showed a decreased association to PML-NBs and the loss of UBC9's ability to delay senescence. We thus propose both pro- and anti-senescence functions of protein SUMOylation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Nucleus / metabolism*
  • Cellular Senescence*
  • Humans
  • Nuclear Proteins / metabolism*
  • Promyelocytic Leukemia Protein / metabolism*
  • Protein Conformation
  • Proteome / analysis*
  • Small Ubiquitin-Related Modifier Proteins / metabolism*
  • Sumoylation
  • Tumor Cells, Cultured
  • Ubiquitin-Conjugating Enzymes / chemistry
  • Ubiquitin-Conjugating Enzymes / metabolism*

Substances

  • Nuclear Proteins
  • Promyelocytic Leukemia Protein
  • Proteome
  • Small Ubiquitin-Related Modifier Proteins
  • PML protein, human
  • Ubiquitin-Conjugating Enzymes
  • ubiquitin-conjugating enzyme UBC9